Phenylephrine Issued a Recall by American Regent

American Regent has issued a recall for an injectable medication because visible particles were found in some samples of a lot, causing safety concerns.

According to the FDA, the recall is in effect for Phenylephrine USP, HCl Injection Lot 0693. The particles found in this lot could cause adverse side effects such as disruption of blood flow within small blood vessels in the lung, granuloma formation, and swelling and redness.

The drug is used to maintain blood level pressure in patients during spinal and inhalation anesthesia and to treat vascular failure in shock, drug-induced hypotension, or hypersensitivity.

There have been no reports of adverse events associated with the recall.

The medication was distributed to wholesalers and distributors throughout the U.S.

If you or a loved one has been harmed by a dangerous drug, you may be entitled to compensation. Contact Sokolove Law for a free legal consultation and to learn about your options.

Tags: